Fixing the injustice of high drug prices: The Tipline for 31 January 2018

This morning’s keenly anticipated state of antitrust news covers pharma litigation in the First Circuit and a bid for class certification in Northern California, plus a preview of a GCR Live Miami panel on efficiencies.

Get unlimited access to all Global Competition Review content